The moderate to severe atopic dermatitis market is experiencing significant growth with 45+ companies developing over 50 pipeline therapies, driven by rising global prevalence and increased awareness of the condition.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.